Through comprehensive discovery and technology platforms, peer-recognized scientific leadership and expertise in oncology, immunology, infectious disease, neurosciences, fibrosis, cardiovascular and metabolic disease, we work collaboratively to rapidly advance programs from target through to preclinical selection and beyond. This integration of capabilities allows a collaborative environment, enabling enhanced efficiency and productivity. We aim to provide outstanding services to our existing partners and to the broader discovery community. Delivering our partners preclinical discoveries through world class capabilities, directed by teams with a reputation for collaboration and scientific excellence. WuXi Biology provides a full spectrum of services and solutions to support stand-alone and integrated projects, from target discovery to candidate selection and into the clinic. Our world-class discovery platform is backed by nearly 3000 scientists, offering expertise in all major disease areas and target classes, across all therapeutic modalities. From small molecules, oligonucleotides, and peptides to antibodies, cell, and gene therapies, our state-of-the-art services, fast turnaround times, and quick study launches meet the diverse needs of our clients. Expertise in synthetic and medicinal chemistry, biology, DMPK and program management for drug discovery.
Panyu District, China
Founded in 2000
10001+ Employees
Working industry
Other
Type of company
Manufacturer, Service provider
Locations
1 Headquarter
Number of products
14 Products
Number of services
2 Services
Specialised areas
drug discovery, immunology, oncology, infectious diseases, chemistry, biology, preclinical, structural biology, medicinal chemistry, crispr
WuXi Discovery Services offers a wide range of products and services
Product
Phase - WuXi Biology
Go to product >
Product
Hit Finding - WuXi Biology
Go to product >
Product
Biomarker Platform - WuXi Biology
Go to product >
Product
Lead Optimization - WuXi Biology
Go to product >
Product
Oncolytic Viruses - WuXi Biology
Go to product >
Product
Translational Platform - WuXi Biology
Go to product >
Product
Pharmacology Studies - WuXi Biology
Go to product >
Product
Natural Products - WuXi Biology
Go to product >
An estimation about the ESG values based on digital data and signals. Important: The ESG scores are only based on information about the country, not the actual company itself
Country:
China
Overall risk estimation:
High
The ESG Data of countries are based on public sources
Environment
E
Grade (A-E)
View details
Social
C
Grade (A-E)
View details
Governance
E
Grade (A-E)
View details
Get insights into the use cases of WuXi Discovery Services
Use case
Application of LUMO in Nucleophilic Reactions - WuXi Biology
< Magical Power of Quantum Mechanics Would you like to predict organic reaction outcomes accurately? Design synthetic sequences with higher rate of success? Would you prefer to learn and rationalize organic chemistry in a data-driven manner? Please join us to unleash the magical power of Quantum Mechanics (QM). First Example We learned that nucleophilic substitution of 2,4-dichloro-5-methylpyrimidine with a nucleophile, such as piperidine, proceeds preferentially at C-4 position (Figure 1). Intuitively it makes more ...Read More >
Use case
Case Study: DEL Data Combined with In Silico Deep-Learning Model - WuXi Biology
DEL in vitro data combined with an in silico deep-learning model provides enhanced predictivity of drug-target interactions.
WuXi Discovery Services operates in 1 country around the world
Get an overview of the locations of WuXi Discovery Services
Location
Country
State
City
Headquarter
China
Guangdong Province
Panyu District
Some frequent questions that have been asked about WuXi Discovery Services
Where is WuXi Discovery Services located?
The company headquarter of WuXi Discovery Services is located in Panyu District, Guangdong Province, China. It's worth noting, that the company may have more locations
How many employees does WuXi Discovery Services approximately have?
As of the latest available information WuXi Discovery Services has around 10001+ employees worldwide.
When was WuXi Discovery Services founded?
WuXi Discovery Services was founded in 2000
In which industries does WuXi Discovery Services mainly work?
The company WuXi Discovery Services has it's main focus in the industries of Other
Check out some interesting alternative companies to WuXi Discovery Services
WuXi AppTec, Laboratory Testing Division, New Jersey site
Plainsboro Township, United States
251-500 Employees
1987
We are passionately committed to our role in enhancing the quality of human lives. We are a unique, world-class, globally integrated testing platform supporting the entire continuum of the drug development journey. We are dedicated to providing you and your program with the highest level of attention. We provide the insights and high-quality data you need to advance your project to the next milestone while meeting international standards for regulatory compliance. WuXi AppTec’s Laboratory Testing Division is a comprehensive integrated testing platform supporting customers across the full spectrum of their development efforts to deliver innovative medicines to patients. Our subject matter experts (SMEs) are there with you every step of the way, to collaborate and work through the unique challenges of drug discovery and development. As your partner, you have access to a team that operates with full transparency and industry leading turnaround times. Our skilled team of toxicologists provide comprehensive safety assessments across a wide range of species and through various routes of administration.
ResearchPoint Global
Austin, United States
51-100 Employees
1999
We are able to work seamlessly within the WuXi AppTec family and/or with outside vendors to provide central lab, manufacturing, bio-analytical testing, biomarker testing, and site management services thus allowing us to offer a more synergistic, one-stop approach to global clinical development. We also offer our services as a functional service provider (FSP) to supplement the needs of our clients, providing key roles and support services as needed to expand their internal resources. With expertise spanning all major therapeutic areas, we deliver the unique blend of an experienced team, combined with the creativity, responsiveness, and customer centric-focus of a highly nimble organization. Through WuXi AppTec’s robust infrastructure, we are able to customize our services to meet our client’s needs, whether full or functional service is required.
WuXi Clinical
Austin, United States
1001-5000 Employees
1999
We are able to work seamlessly within the WuXi AppTec family and/or with outside vendors to provide central lab, manufacturing, bio-analytical testing, biomarker testing, and site management services thus allowing us to offer a more synergistic, one-stop approach to global clinical development. We also offer our services as a functional service provider (FSP) to supplement the needs of our clients, providing key roles and support services as needed to expand their internal resources. With expertise spanning all major therapeutic areas, we deliver the unique blend of an experienced team, combined with the creativity, responsiveness, and customer centric-focus of a highly nimble organization. Through WuXi AppTec’s robust infrastructure, we are able to customize our services to meet our client’s needs, whether full or functional service is required.
BirdoTech
Shanghai, China
501-1000 Employees
2015
We are committed to providing the highest quality services to drug discovery companies addressing worldwide healthcare needs. The world’s top pharmaceuticals companies and institutes are also our partners. We have been tested to meet time sensitive deadlines supporting critical clinical trials. We leverage our significant scientific foundation to maximize the collaborative value with our partners. With 25,000m2 of R&D laboratory space distributed over 4 sites throughout China, our partners gain the maximum flexibility in leveraging our services in medicinal chemistry SAR development, synthetic route scouting, process optimization, and production to multi-ton scale.
WuXi Biologics
Langqiao, China
5001-10000 Employees
2014
We provide world-class expertise in both platform and novel conjugation technologies and can handle highly potent and toxic payloads. We provide quality assurance, quality control and operational systems that meet or exceed worldwide regulatory standards. We are dedicated to implementing sustainable and eco-friendly business practices by building a comprehensive and integrated Environmental, Health and Safety (EHS) management system, sourcing ethically, reducing our environmental footprint, advocating reduced energy consumption, minimizing effluent, and acting responsibly to reduce operational impact on the environment. WuXi XDC, a WuXi Biologics subsidiary, and a leading Contract Research, Development and Manufacturing Organization (CRDMO), is a joint venture between WuXi Biologics and the WuXi AppTec subsidiary, WuXi STA. WuXi XDC provides single-source development and manufacturing platforms for small molecule linkers / payloads and biologics (e.g., monoclonal, bispecific and multispecific antibodies or other recombinant proteins) intermediates with the company’s leading bioconjugation discovery, development and manufacturing services. The WuXi XDC one-stop service and technology platform provides for our clients an unmatched value chain for the development of ADCs and other bioconjugates including conjugated diagnostic and imaging reagents. We offer a full range of services including both integrated mAb, payload-linker and bioconjugate development packages and standalone CMC development and drug substance (DS) and drug product (DP) manufacturing packages just for the bioconjugate or intermediates. We extend our extensive bioconjugation services for diagnostic and imaging reagents and we also provide “ready-made” GMP-grade chemical payloads / linkers, many with an existing Drug Master File (DMF).
Drug Discovery and Development Consultants Ltd
Cambridge, United Kingdom
1-10 Employees
2018
We are able to achieve this through deploying a team of highly experienced scientists with core competencies across a broad range of disciplines including in vitro/in vivo biology, medicinal chemistry, DMPK, pre-clinical development (CMC, tox, scale-up) through clinical development (operations, management, regulatory). With more than a hundred years of experience in both biotech and pharma across the discovery and development spectrum, our team has the skill sets and experience to provide practical, cost-efficient and timely solutions to your project through consultation on an individual basis or as a team. Provide support and advice for in-licensing or out-licensing of assets or technologies.